Which scenario best describes extralabel drug use?

Which scenario best describes extralabel drug use?

• A. All of the above constitute extralabel drug use.
• B. Only a and b constitute extralabel drug use.
• C. Dose adjustment to every 12 hours constitutes extralabel drug use.
• D. None of the above constitutes extralabel drug use.

Answer: (A)

Extralabel drug use means using a drug in a way that is not described on the product’s label. This includes changes to the indication, the species being treated, the route of administration, the dose, the frequency or duration of dosing, and the withdrawal times for food-producing animals. If the label calls for a certain dosing interval and a veterinarian adjusts it to every 12 hours, that constitutes extralabel use because the dosing schedule no longer matches the label. If the other scenarios described in the question also involve departures from the labeled use (for example, a different indication or a different route), they likewise fall under extralabel use. When all the scenarios involve such departures, the collective answer is that all of them describe extralabel drug use. In practice, extralabel use is allowed only under specific veterinary guidelines (such as AMDUCA) and with safeguards: it’s used when there is no approved product for the condition, when the veterinarian documents the rationale, ensures safety and efficacy considerations, and, for food animals, observes appropriate withdrawal times.

Extralabel drug use means using a drug in a way that is not described on the product’s label. This includes changes to the indication, the species being treated, the route of administration, the dose, the frequency or duration of dosing, and the withdrawal times for food-producing animals. If the label calls for a certain dosing interval and a veterinarian adjusts it to every 12 hours, that constitutes extralabel use because the dosing schedule no longer matches the label.

If the other scenarios described in the question also involve departures from the labeled use (for example, a different indication or a different route), they likewise fall under extralabel use. When all the scenarios involve such departures, the collective answer is that all of them describe extralabel drug use.

In practice, extralabel use is allowed only under specific veterinary guidelines (such as AMDUCA) and with safeguards: it’s used when there is no approved product for the condition, when the veterinarian documents the rationale, ensures safety and efficacy considerations, and, for food animals, observes appropriate withdrawal times.